Intern, Bioprocess Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

Denali Therapeutics · 1 day ago

Intern, Bioprocess Development

positionSouth San Francisco, CA
timeInternship
remoteOnsite
seniorityIntern
money$22.11/hr - $27.40/hr
workcardStart in 2026 Summer

Denali Therapeutics is a biotechnology company dedicated to developing breakthrough therapies for neurodegenerative diseases. They are seeking an Intern for the Bioprocess Development group to optimize conditions for CHO cell lines and gain hands-on experience in biologics process development and manufacturing.

BiotechnologyGeneticsHealth DiagnosticsTherapeutics
check
H1B Sponsor Likelynote

Responsibilities

Work under supervision of Denali scientists to design, execute and interpret cell culture experiments
Perform and analyze shake flask and lab-scale bioreactor fed-batch production experiments
Learn to use cell culture lab instruments such as such as Vi-Cell, Nova Flex2 and Octet
Analyze results and present work to bioprocess development group

Qualification

Mammalian cell cultureAseptic techniquesBioreactor experienceExperimental data analysisMS Office SuiteCuriosityCollaborationCommunication skillsOrganizational skillsAdaptability

Required

Candidates pursuing a BS or MS in Biology, Chemical Engineering or related field
Familiarity with basic laboratory skills such as pipetting, material weighting, etc
Demonstrated ability to organize, analyze and interpret experimental data
Self- and results-driven, organized, resourceful, adaptable and collaborative
Bold and creative thinker with a curious nature, eager to learn about the complexities of the business of healthcare and biotech
Evident communication and analytical skills
High degree of proficiency with the MS Office Suite or Google equivalent

Preferred

Previous hands-on lab experience with mammalian cell culture including aseptic techniques is highly desired

Benefits

Paid holiday time off is based on Denali's designated holidays.
Interns who live more than 50 miles away from the office are eligible for an additional housing stipend.

Company

Denali Therapeutics

twittertwitter
company-logo
Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
dateFounded in 2013
location
San Francisco, California, USA
people-size501-1000 employees
web-link
https://www.denalitherapeutics.com

H1B Sponsorship

Denali Therapeutics has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (11)
2024 (14)
2023 (7)
2022 (6)
2021 (5)
2020 (1)

Funding

Current Stage
Public Company
Total Funding
$1.32B
Key Investors
Royalty PharmaBaillie Gifford
2025-12-04Post Ipo Debt· $200M
2024-02-27Post Ipo Equity· $500M
2022-10-19Post Ipo Equity· $275M

Leadership Team

leader-logo
Ryan Watts
CEO
linkedin
leader-logo
Peter Chin
Sr. Vice President & Head of Late-Stage Clinical Development and Medical Affairs
linkedin

Recent News

GlobeNewswire
Denali Therapeutics Announces Key Anticipated Milestones and Priorities for 2026 Including Commercial Launch of Tividenofusp Alfa for Hunter Syndrome
2026-01-06
Longevity.Technology
NEJM publishes Phase 1/2 study of Denali’s tividenofusp alfa in Hunter syndrome
2026-01-03
MarketScreener
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
2025-12-30
Company data provided by crunchbase